ESOPHAGEAL AND/OR CARDIA CANCER

Clinical trials for ESOPHAGEAL AND/OR CARDIA CANCER explained in plain language.

Never miss a new study

Get alerted when new ESOPHAGEAL AND/OR CARDIA CANCER trials appear

Sign up with your email to follow new studies for ESOPHAGEAL AND/OR CARDIA CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New cancer drug candidate HLX18 faces off against OPDIVO® in early trial

Disease control Not yet recruiting

This early-stage study tests whether a new drug, HLX18, works similarly to the approved cancer drug OPDIVO®. About 174 adults with esophageal cancer, melanoma, or bladder cancer who had surgery will receive either HLX18 or OPDIVO®. The goal is to compare how the drugs move throug…

Matched conditions: ESOPHAGEAL AND/OR CARDIA CANCER

Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control

Last updated May 20, 2026 11:57 UTC

ESOPHAGEAL AND/OR CARDIA CANCER

Get alerted when new ESOPHAGEAL AND/OR CARDIA CANCER trials appear

New cancer drug candidate HLX18 faces off against OPDIVO® in early trial